Bristol-Myers Squibb Company Ce (CELG.RI) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bristol-Myers Squibb Company Ce (CELG.RI:NYSE), powered by AI.
- Current Price
- $0.12
- P/E Ratio
- 0.2
- Market Cap
- 2.5B
- Sector
- Unknown
What is the Bristol-Myers Squibb Company Ce stock price forecast?
Bristol-Myers Squibb Company Ce is currently trading at $0.12. View real-time AI analysis on Alpha Lenz.
What is Bristol-Myers Squibb Company Ce insider trading activity?
View the latest insider trading data for Bristol-Myers Squibb Company Ce on Alpha Lenz.
What is Bristol-Myers Squibb Company Ce's P/E ratio?
Bristol-Myers Squibb Company Ce's P/E ratio is 0.2.
Bristol-Myers Squibb Company Ce
NYSE · CELG.RI“Bristol-Myers Squibb Company Ce trades at a P/E of 0.2 (undervalued) with strong ROE of 27.4%.”
Ask for details →Company Overview
Company Statistics
FY 2021Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Bristol-Myers Squibb Company Ce trades at a P/E of 0.2 (undervalued) with strong ROE of 27.4%.”
Ask for details →Frequently Asked Questions
Bristol-Myers Squibb Company Ce (ticker: CELG.RI) is a company listed on NYSE in the Unknown sector (Unknown). Market cap is $2.5B.
The current price is $0.123 with a P/E ratio of 0.17x and P/B of 0.04x.
ROE is 27.42% and operating margin is 7.19%. Annual revenue is $255.1B.